MACKENZIE FINANCIAL CORP
Position in NBIX — Neurocrine Biosciences Inc
CIK 919859
TORONTO ONTARIO, A6
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,609,949
+$17,532,422 QoQ
Shares Held
175,685
+91.6% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#92
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,609,949 | 175,685 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,077,527 | 91,677 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,898,217 | 76,840 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,914,612 | 84,874 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,516,869 | 75,717 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,523,655 | 86,109 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $7,537,666 | 55,221 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $9,976,093 | 86,583 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,228,813 | 88,827 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,662,435 | 91,810 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,761,614 | 96,855 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $10,758,487 | 95,631 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $8,708,982 | 92,354 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,888,723 | 48,298 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $4,714,177 | 39,469 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,766,525 | 35,463 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $4,204,897 | 43,136 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,802,750 | 29,896 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $868,137 | 10,193 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,412,370 | 14,726 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $944,879 | 9,709 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $957,426 | 9,845 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,645,073 | 17,163 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,574,908 | 16,378 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,016,748 | 8,334 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $652,154 | 7,535 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||